Radiotherapy and concurrent chemotherapy (CRT) is superior to radiotherapy alone for the
treatment of locally advanced, nonmetastatic squamous carcinoma of the head and neck …

Cure of locally advanced squamous cell carcinoma of the head and neck (SCCHN) is
uncommon with radiotherapy alone. The desire for organ preservation in advanced …

Concurrent chemoradiotherapy (CRT) has been shown to be superior to radiotherapy (RT)
alone in several clinical therapeutic settings for head and neck cancer (HNC). In …

Background The purpose of this study was to report the results of a phase III, 3‐arm,
randomized trial comparing conventional radiotherapy (RT) to concurrent …

Optimizing locoregional control, disease-free, and overall survival remains a challenging
goal in the management of squamous cell carcinoma of the head and neck. Despite near …

This review will discuss the evolution of the role of chemotherapy in the treatment of locally
advanced head and neck cancer (HNC), over the last few decades. Studies were identified …

Background Since 1989, 105 patients with squamous head and neck cancer have been
treated with combined chemoradiotherapy. Objective To examine the effectiveness of using …

Head and neck cancer is best managed in a multidisciplinary setting. Surgery, radiation
therapy, chemotherapy and, more recently, biologic therapy are often employed in various …

Background Concurrent chemoradiotherapy (CCRT) is the standard treatment for patients
with unresectable, nonmetastatic locoregionally advanced squamous-cell carcinoma of the …

Purpose A retrospective review with long-term follow-up is reported from the Cleveland
Clinic Foundation studying radiation and concurrent multiagent chemotherapy in patients …